We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
55.65%
This Fund
S&P 500
This Quarter
Est. Return
+1.98%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$12.6B
AUM Growth
+$483M
(+4%)
Cap. Flow
+$456M
Cap. Flow
% of AUM
3.63%
Top 10 Holdings %
Top 10 Hldgs %
12.52%
Holding
374
New
23
Increased
192
Reduced
117
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aramark
ARMK
|
+$63.2M |
| 2 |
Expedia Group
EXPE
|
+$60.6M |
| 3 |
Bath & Body Works
BBWI
|
+$52.7M |
| 4 |
Moody's
MCO
|
+$44M |
| 5 |
Genpact
G
|
+$38.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pediatrix Medical
MD
|
+$71.5M |
| 2 |
WR
Westar Energy Inc
WR
|
+$46.6M |
| 3 |
GNC
GNC Holdings, Inc.
GNC
|
+$45.7M |
| 4 |
ELLI
Ellie Mae Inc
ELLI
|
+$39.1M |
| 5 |
FCS
FAIRCHILD SEMICONDUCTOR INTL INC COMMON
FCS
|
+$38.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.78% |
| 2 | Industrials | 19.59% |
| 3 | Financials | 13.29% |
| 4 | Consumer Discretionary | 11.15% |
| 5 | Healthcare | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMWD
251
DELISTED
American Woodmark
AMWD
| $8.09M | 0.06% |
108,489
+33,576
| +45% | +$2.26M |
|
252
Celldex Therapeutics
CLDX
$2.91B
| $8.08M | 0.06% |
142,581
-13,132
| -8% | -$1.48M |
|
253
Acadia Pharmaceuticals
ACAD
$4.53B
| $7.89M | 0.06% |
282,199
-63,185
| -18% | -$1.38M |
|
|
RP
254
DELISTED
RealPage, Inc.
RP
| $7.79M | 0.06% |
374,033
-82,401
| -18% | -$1.63M |
|
255
Leidos
LDOS
$14.5B
| $7.76M | 0.06% |
154,207
-1,722
| -1% | -$82.1K |
|
256
Carlisle Companies
CSL
$13.3B
| $7.41M | 0.06% |
74,450
-25,301
| -25% | -$2.23M |
|
257
Dana Inc
DAN
$2.94B
| $6.93M | 0.06% |
492,170
+9,172
| +2% | +$115K |
|
258
Silicon Laboratories
SLAB
$7.18B
| $6.85M | 0.05% |
152,411
-15
| -0% | -$645 |
|
259
Viatris
VTRS
$20.9B
| $6.71M | 0.05% |
144,754
-143
| -0.1% | -$6.9K |
|
260
Artisan Partners
APAM
$2.85B
| $6.46M | 0.05% |
209,366
+702
| +0.3% | +$20.5K |
|
261
PTC Therapeutics
PTCT
$6.24B
| $6.23M | 0.05% |
967,367
+715,383
| +284% | +$12.4M |
|
|
CSOD
262
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $6.03M | 0.05% |
184,054
-556,045
| -75% | -$16.8M |
|
263
LPL Financial
LPLA
$27.4B
| $6M | 0.05% |
241,817
+817
| +0.3% | +$22.1K |
|
|
PAY
264
DELISTED
Verifone Systems Inc
PAY
| $5.82M | 0.05% |
206,033
-69
| -0% | -$1.71K |
|
265
QuickLogic
QUIK
$216M
| $5.74M | 0.05% |
386,439
-5,139
| -1% | -$92.5K |
|
266
LSB Industries
LXU
$837M
| $5.69M | 0.05% |
580,613
+19,476
| +3% | +$113K |
|
|
ZNGA
267
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $5.57M | 0.04% |
2,441,996
-3,778,031
| -61% | -$8.45M |
|
268
Steel Dynamics
STLD
$36.8B
| $5.42M | 0.04% |
+240,601
| New | +$4.53M |
|
|
ITCI
269
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.38M | 0.04% |
193,614
-115,080
| -37% | -$3.84M |
|
|
SGMO
270
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $5.01M | 0.04% |
827,567
-2,084
| -0.3% | -$12.5K |
|
|
HABT
271
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $4.98M | 0.04% |
267,507
-3,171
| -1% | -$64.4K |
|
|
TEN
272
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $4.82M | 0.04% |
93,637
-449
| -0.5% | -$19.7K |
|
273
Visteon
VC
$2.86B
| $4.45M | 0.04% |
55,908
-94,419
| -63% | -$7.44M |
|
274
Granite Construction
GVA
$5.12B
| $4.3M | 0.03% |
+90,000
| New | +$3.66M |
|
275
United Therapeutics
UTHR
$26.1B
| $4.28M | 0.03% |
38,424
-9,807
| -20% | -$1.24M |
|
Similar funds
HL
DCP
CCM
URS
CIM
MPI
TIM
DPIM
Frontier Capital Management's Q1 2016 Portfolio in Review
As of Q1 2016, Frontier Capital Management held 374 positions worth $12.6B, up 4% from $12.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Frontier Capital Management deployed $456M of net new capital in Q1 2016, opening 23 new positions and adding to 192 existing holdings. Its largest new stake was Expedia Group: 568,316 shares worth $61.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Pediatrix Medical, an estimated $71.5M trimmed.
- Frontier Capital Management's largest Q1 2016 buy was Expedia Group: 568,316 shares worth $61.3M.
- Frontier Capital Management added most to Aramark in Q1 2016, an estimated $63.2M increase.
- Frontier Capital Management's biggest Q1 2016 reduction was Pediatrix Medical, cutting an estimated $71.5M.
- Frontier Capital Management fully exited Cabot Corp in Q1 2016, selling an estimated $30.8M.
- Frontier Capital Management's ten largest holdings make up 13% of its $12.6B portfolio in Q1 2016.
- Frontier Capital Management opened 23 new positions and closed 32 in Q1 2016.
- Frontier Capital Management's portfolio value rose 4% quarter-over-quarter to $12.6B.
Based on Frontier Capital Management's 13F filing for Q1 2016, filed 4 May 2016.